The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients
Open accessAbstract
Recurrent hepatitis occurs in the majority of patients undergoing liver transplantation for hepatitis C virus (HCV) cirrhosis, with progression to cirrhosis in up to 30% after 5 years. Based on these data, a decrease in survival can be anticipated with prolonged follow-up. Furthermore, posttransplantation HCV-fibrosis progression has been shown in recent years to increase. Our aims were (1) to describe the natural history of HCV-infected recipients, particularly to determine whether survival has decreased in recent years; (2) to compare this outcome with that observed in non-HCV-infected cirrhosis controls; and (3) to determine the factors associated with disease severity and survival. Among 522 cirrhotic patients undergoing transplantation between 1991 and 2000, 283 (54%) were infected with HCV. Yearly biopsies were performed in these recipients and at 1 and 5 years in the remainder. With similar follow-up, the percentage of deaths in the HCV(+) group was significantly higher than in the HCV(−) group (37% vs. 22%, P < .001), and patient survival was lower (77%, 61%, 55% vs. 87%, 76%, 70% at 1, 5, and 7 years, respectively; P = .0001). Although survival has increased in the HCV(−) group in recent years, it has significantly decreased in HCV recipients (P < .0001). The main cause of death among the latter was decompensated graft cirrhosis (n = 23/105, 22%), whereas that of HCV(−) patients was infections (n = 10/52, 19%). Reasons for the recent worse outcome in HCV(+) recipients include the increased donor age and stronger immunosuppression. In conclusion, patient survival is lower among HCV(+) recipients than among HCV(−) ones and has been decreasing in recent years. The aging of donors is a major contributor to this worse outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
Long-Term Outcome of Hepatitis C Infection after Liver Transplantation
Gane, E. J., Portmann, B. C., Naoumov, N. V., Smith, H. M., Underhill, J. A., Donaldson, P. T., Maertens, G., & Williams, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603283341302 · Cited by 969
HCV-related fibrosis progression following liver transplantation: increase in recent years
Berenguer, M., Ferrell, L., Watson, J., Prieto, M., Kim, M., Rayón, M., Córdoba, J., Herola, A., Ascher, N., Mir, J., et al. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80231-7 · Cited by 748
Self-citationBerenguer, M., Prieto, M., Rayón, J. M., Mora, J., Pastor, M., Ortiz, V., Carrasco, D., Juan, F. S., Burgueño, M.-D.-J., Mir, J., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.17924 · Cited by 544
Self-citationPrieto, M., Berenguer, M., Rayón, J. M., Córdoba, J., Argüello, L., Carrasco, D., García-Herola, A., Olaso, V., De Juan, M., Gobernado, M., et al. (1999) · Hepatology · doi:10.1002/hep.510290122 · Cited by 537
Self-citationPredictors of patient and graft survival following liver transplantation for hepatitis C
Charlton, M., Seaberg, E., Wiesner, R., Everhart, J., Zetterman, R., Lake, J., Detre, K., & Hoofnagle, J. (1998) · Hepatology · doi:10.1002/hep.510280333 · Cited by 537
Féray, C., Caccamo, L., Alexander, G. J. M., Ducot, B., Gugenheim, J., Casanovas, T., Loinaz, C., Gigou, M., Burra, P., Barkholt, L., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70454-3 · Cited by 354
Sigal, S. H., Rajvanshi, P., Gorla, G. R., Sokhi, R. P., Saxena, R., Gebhard, D. R., Reid, L. M., & Gupta, S. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.5.g1260 · Cited by 230
Busquets, J., Xiol, X., Figueras, J., Jaurrieta, E., Torras, J., Ramos, E., Rafecas, A., Fabregat, J., Lama, C., Iba??ez, L., et al. (2001) · Transplantation · doi:10.1097/00007890-200106270-00011 · Cited by 175
Cited by
Natural history of hepatitis C.
Westbrook, R. H., & Dusheiko, G. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.012 · Cited by 1,049
Durand, F., Levitsky, J., Cauchy, F., Gilgenkrantz, H., Soubrane, O., & Francoz, C. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.009 · Cited by 320
Ryder, S. D. (2004) · Gut · doi:10.1136/gut.2003.021691 · Cited by 276
Fibrosis and disease progression in hepatitis C
Marcellin, P., Asselah, T., & Boyer, N. (2002) · Hepatology · doi:10.1002/hep.1840360707 · Cited by 267
Verran, D., Kusyk, T., Painter, D., Fisher, J., Koorey, D., Strasser, S., Stewart, G., & McCaughan, G. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50099 · Cited by 259
Metadata
- Authors
- Berenguer, M., Prieto, M., Juan, F. S., Rayón, J. M., Martinez, F., Carrasco, D., Moya, A., Orbis, F., Mir, J., & Berenguer, J.
- Venue
- Hepatology
- Published
- 2002-07
- Volume
- 36
- Issue
- 1
- Pages
- 202-210
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1966112709
- Cited by
- 599
- References
- 11
- FWCI
- 28.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. https://app.cochat.ai/papers/10.1053/jhep.2002.33993
- The paper
- Berenguer, M., Prieto, M., Juan, F. S., Rayón, J. M., Martinez, F., Carrasco, D., Moya, A., Orbis, F., Mir, J., & Berenguer, J. (2002). Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology. https://doi.org/10.1053/jhep.2002.33993
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.